In one collaborative study, we assessed the diagnostic performance and clinical utility of various thyroid function tests in 135 patients with central (secondary and tertiary) hypothyroidism. As expected, we found that, in contrast to patients with pri-mary hypothyroidism, measurement of thyrotropin (thyroid stimulating hormone) cannot be used to assess the clinical thyroid status in central hypothyroid patients. Determination of free thyroxine with analytically sound and clinically validated methods usually was reli-able for guiding levothyroxine replacement therapy in these patients. In another study, we developed a new approach using quantitative research synthesis for assessing the effects of thyrotropin suppression by thyroid hormones on benign solitary thyroid nodules. This approach involved systematic review of the literature for clinical studies and expert opinions, meta-analysis of selected interventional studies, survey of NIH endocrinology practitioners for therapeutic decisions in hypothetical patients with benign solitary thyroid nodule, prac-tice validation in NIH patients treated with levothyroxine suppression for benign solitary thyroid nodules, and application of Hills criteria to assess causality between thyroid sup-pression therapy and regression of benign solitary thyroid nodules. We concluded that since approximately one-quarter of patients with benign solitary thyroid nodule may respond with a clinically significant (>50 percent) reduction in nodule size to levothyroxine suppression therapy, an initial trial of this therapy is warranted in all of these patients in the absence of contraindication(s) to levothyroxine administration. In other studies now in progress we are assessing the clinical utility of thyrotropin sup-pression by thyroid hormones in patients with multinodular goiter, further, we are studying the effects of various blood collection tubes on the measurements of free thyroxine and thyrotropin thyroid stimulating hormone with different non-isotopic methods.

Agency
National Institute of Health (NIH)
Institute
Clinical Center (CLC)
Type
Intramural Research (Z01)
Project #
1Z01CL010305-01
Application #
6227893
Study Section
Cognition and Perception Study Section (CP)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Clinical Center
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Celi, Francesco S; Zemskova, Marina; Linderman, Joyce D et al. (2009) The pharmacodynamic equivalence of levothyroxine and liothyronine. A randomized, double blind, cross-over study in thyroidectomized patients. Clin Endocrinol (Oxf) :
Bowen, Raffick A R; Vu, Chi; Remaley, Alan T et al. (2007) Differential effect of blood collection tubes on total free fatty acids (FFA) and total triiodothyronine (TT3) concentration: a model for studying interference from tube constituents. Clin Chim Acta 378:181-93
Eisenhofer, Graeme; Lenders, Jacques W M; Goldstein, David S et al. (2005) Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin Chem 51:735-44
Bowen, Raffick A R; Chan, Yung; Ruddel, Mark E et al. (2005) Immunoassay interference by a commonly used blood collection tube additive, the organosilicone surfactant silwet L-720. Clin Chem 51:1874-82
Bowen, Raffick A R; Chan, Yung; Cohen, Joshua et al. (2005) Effect of blood collection tubes on total triiodothyronine and other laboratory assays. Clin Chem 51:424-33
Eisenhofer, Graeme; Goldstein, David S; Sullivan, Patricia et al. (2005) Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 90:2068-75
McGriff, Nayahmka J; Csako, Gyorgy; Gourgiotis, Loukas et al. (2002) Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med 34:554-64
Csako, G; McGriff, N J; Rotman-Pikielny, P et al. (2001) Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders. Ann Pharmacother 35:1578-83
Collins, M T; Remaley, A T; Csako, G et al. (2000) Increased levothyroxine requirements presenting as ""inappropriate"" TSH secretion syndrome in a patient with nephrotic syndrome. J Endocrinol Invest 23:383-92
Csako, G; Byrd, D; Wesley, R A et al. (2000) Assessing the effects of thyroid suppression on benign solitary thyroid nodules. A model for using quantitative research synthesis. Medicine (Baltimore) 79:26-Sep

Showing the most recent 10 out of 11 publications